Suchergebnisse - "Patel, Sunil"

PubPharm (17)

1

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

enthalten in: Lancet (London, England) | 2024

von Brown, D. | Boyer, D. | Do, D. | +124

2

Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration : 1-year and switching results of a phase 3 clinical trial

enthalten in: BMJ open ophthalmology | 2023

von Woo, S. | Sadda, S. | Bradvica, M. | +16

3

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2023

von Woo, S. | Bradvica, M. | Vajas, A. | +16

4

A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

enthalten in: Ophthalmology | 2023

von Jackson, T. | Slakter, J. | Buyse, M. | +108

5

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

enthalten in: Translational vision science & technology | 2021

von Dugel, P. | Khanani, A. | Berger, B. | +5

6

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration : The AVENUE Phase 2 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2020

von Sahni, J. | Dugel, P. | Patel, S. | +9

7

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration : The STAIRWAY Phase 2 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2020

von Khanani, A. | Patel, S. | Ferrone, P. | +7

CommentIn: JAMA Ophthalmol. 2020 Sep 1;138(9):972-973. - PMID 32729885

8

Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration : Results of the Phase 2 CAPELLA Trial

enthalten in: Ophthalmology | 2020

von Heier, J. | Wykoff, C. | Waheed, N. | +10

CommentIn: Ophthalmology. 2021 Oct;128(10):e69-e70. - PMID 33992471

9

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema : BOULEVARD Phase 2 Randomized Trial

enthalten in: Ophthalmology | 2019

von Sahni, J. | Patel, S. | Dugel, P. | +12

10

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

enthalten in: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2018

von Callanan, D. | Kunimoto, D. | Maturi, R. | +8